Drug
Transdermal Placebo Patch
Transdermal Placebo Patch is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
2(33%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_2
2
33%
Ph not_applicable
1
17%
Ph phase_4
2
33%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(4)
Detailed Status
Completed4
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
completed467%
recruiting233%
Recent Activity
2 active trials
Showing 5 of 6
completedphase_2
Depressed Mood Improvement Through Nicotine Dosing 3
NCT05746273
recruitingphase_4
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
NCT06610305
completedphase_2
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
NCT03018366
recruitingphase_4
Cardiometabolic Consequences of the Loss of Ovarian Function
NCT06264882
completednot_applicable
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
NCT00608062
Clinical Trials (6)
Showing 6 of 6 trials
NCT05746273Phase 2
Depressed Mood Improvement Through Nicotine Dosing 3
NCT06610305Phase 4
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
NCT03018366Phase 2
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
NCT06264882Phase 4
Cardiometabolic Consequences of the Loss of Ovarian Function
NCT00608062Not Applicable
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
NCT01526005
Brain Nicotine Receptor Density & Response to Nicotine Patch
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6